| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $14.2M | -15.0% |
| Cost of Revenue | $7.1M | -12.8% |
| Gross Profit | $7.1M | -17.1% |
| R&D Expense | $50.6M | -4.6% |
| SG&A Expense | $56.6M | -4.0% |
| Operating Income | -$100.1M | +3.2% |
| Pre-tax Income | -$86.5M | -0.3% |
| Income Tax | $98K | — |
| Net Income | -$86.6M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $40.8M | +25.4% |
| Inventory | $7.4M | +65.6% |
| Current Assets | $253.3M | -23.4% |
| Total Assets | $366.6M | -16.0% |
| Current Liabilities | $15.3M | +15.9% |
| Total Liabilities | $39.0M | -0.9% |
| Stockholders' Equity | $327.6M | -17.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$46.1M | +21.9% |
| Capital Expenditures | $3.6M | -51.0% |
| Investing Cash Flow | $65.9M | +73.7% |
| Financing Cash Flow | -$11.5M | -2643.1% |
| Free Cash Flow | -$49.7M | +25.1% |
| -0.4% |